Soft tissue sarcoma Clinical Trials
Recruiting soft tissue sarcoma studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat soft tissue sarcoma. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting soft tissue sarcoma studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting soft tissue sarcoma trials
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas
Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Prospective Phase I/II Study Evaluating the Safety and Efficacy of Preoperative Carbon Ion Radiotherapy in Patients With Soft Tissue Sarcoma : The SARCOMA-01 Trial by the Severance sARCOma Multidisciplinary Team
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Agnostic Therapy in Rare Solid Tumors
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
Pre-operative Hypofractionated Proton Therapy
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
IVIM & OLINK in Sarcoma
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
5-Day Preoperative Radiation for Soft Tissue Sarcoma
A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Use of GnRHa During Chemotherapy for Fertility Protection
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
Genomic Risk in Retroperitoneal Sarcoma
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
HIFU Ablation of Soft Tissue Sarcoma
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
tTF-NGR Randomized Study - STS
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
Adriamycin and Ifosfamide Combined With Sintilimab
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Exercise and Soft Tissue Sarcoma
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Toripalimab Combined With CAV/IE Regimen
Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Soft tissue sarcoma clinical trials — common questions
Are soft tissue sarcoma clinical trials free to join?
Yes. Participating in a soft tissue sarcoma clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a soft tissue sarcoma clinical trial?
Each soft tissue sarcoma study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a soft tissue sarcoma trial near me?
Use the location controls above. We'll show recruiting soft tissue sarcoma trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many soft tissue sarcoma trials are recruiting right now?
We're currently tracking roughly 24 recruiting soft tissue sarcoma trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.